
February 15, 2026
Genomic variability of Mycobacterium tuberculosis and clinical outcomes in Africa.
We are deciphering the genomic diversity of Mtb circulating in Africa to better understand its implications for clinical phenotypes

We are deciphering the genomic diversity of Mtb circulating in Africa to better understand its implications for clinical phenotypes

We are currently strengthening genomic surveillance capacity in Rwanda, with the aim of expanding this initiative to other African countries and advancing genomic epidemic intelligence across the continent.

We are conducting a multi-country study to validate a framework for the implementation and scale-up of long-acting injectable therapies.